Form D · Other Technology
3F BIO LTD
Glasgow, Scotland, X0 · CIK 0002013163
Offering snapshot reported Mar 1, 2024 · SEC filing
- Reported sold
- $7.24M Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 8, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 1, 2024 | Initial | $7,239,834 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506490
Source: Form D, filed Mar 1, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arnoud Balhuizen | Director |
| Nicholas Reginald Elmslie | Director |
| Elaine Ferguson | Director |
| Harry Kalms | Director |
| Vinod Kanbi | Director |
| Robert James Taylor Laird | Director |
| Guy William Semmens | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
163 Bath Street
Glasgow, Scotland, X0, G2 4SQ
Glasgow, Scotland, X0, G2 4SQ